- Home
- STTK vs HFFG Comparison
STTK vs HFFG Comparison
Compare STTK & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STTK
- HFFG
- Stock Information
- Founded
- STTK 2016
- HFFG N/A
- Country
- STTK United States
- HFFG United States
- Employees
- STTK N/A
- HFFG N/A
- Industry
- STTK Biotechnology: Pharmaceutical Preparations
- HFFG Food Distributors
- Sector
- STTK Health Care
- HFFG Consumer Discretionary
- Exchange
- STTK Nasdaq
- HFFG Nasdaq
- Market Cap
- STTK 173.6M
- HFFG 162.4M
- IPO Year
- STTK 2020
- HFFG N/A
- Fundamental
- Price
- STTK $3.86
- HFFG $3.17
- Analyst Decision
- STTK Strong Buy
- HFFG
- Analyst Count
- STTK 3
- HFFG 0
- Target Price
- STTK $10.67
- HFFG N/A
- AVG Volume (30 Days)
- STTK 150.7K
- HFFG 33.5K
- Earning Date
- STTK 11-07-2024
- HFFG 08-06-2024
- Dividend Yield
- STTK N/A
- HFFG N/A
- EPS Growth
- STTK N/A
- HFFG N/A
- EPS
- STTK N/A
- HFFG 0.07
- Revenue
- STTK $4,123,999.00
- HFFG $1,160,322,000.00
- Revenue This Year
- STTK $164.45
- HFFG N/A
- Revenue Next Year
- STTK N/A
- HFFG N/A
- P/E Ratio
- STTK N/A
- HFFG $44.16
- Revenue Growth
- STTK 380.09
- HFFG N/A
- 52 Week Low
- STTK $1.33
- HFFG $2.46
- 52 Week High
- STTK $11.76
- HFFG $5.91
- Technical
- Relative Strength Index (RSI)
- STTK 57.18
- HFFG 47.30
- Support Level
- STTK $3.37
- HFFG $3.08
- Resistance Level
- STTK $3.75
- HFFG $3.31
- Average True Range (ATR)
- STTK 0.24
- HFFG 0.22
- MACD
- STTK 0.08
- HFFG -0.02
- Stochastic Oscillator
- STTK 88.57
- HFFG 15.25
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.